advanced pancreatic cancer
Showing 1 - 25 of >10,000
Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Modena (Olaparib 150 MG)
Recruiting
- Advanced Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Olaparib 150 MG
-
Modena, ItalyAou Modena
Oct 5, 2023
Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Stereotactic body radiation(SBRT)
- Zimberelimab (GLS-010)
- (no location specified)
Aug 22, 2023
Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- DaRT seeds insertion
- (no location specified)
Sep 5, 2023
Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX plus radiotherapy
- (no location specified)
Nov 21, 2023
Advanced Pancreatic Cancer Trial in Shanghai (Pimicotinib (ABSK021))
Recruiting
- Advanced Pancreatic Cancer
- Pimicotinib (ABSK021)
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Oct 26, 2023
Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)
Recruiting
- Advanced Pancreatic Cancer
- Personalized neoantigen tumor vaccine
-
Qionghai, Hainan, ChinaRuijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))
Recruiting
- Pancreatic Cancer
- TCR-T Cells Injection(GB3010 Cells Injection)
-
ShangHai, Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023
Locally Advanced Pancreatic Cancer Trial in Guangzhou (Sulfatinib, Serplulimab, Albumin-paclitaxel)
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Sulfatinib
- +3 more
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital, Sun Yat-Sen University
Aug 10, 2023
Progression-free Survival Trial (Sovalteinib Solutumab Tegeo)
Not yet recruiting
- Progression-free Survival
- Sovalteinib Solutumab Tegeo
- (no location specified)
Jul 24, 2023
Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023
Advanced Pancreatic Cancer Trial in Shanghai (JS107, JS107 combination with Toripalimab)
Not yet recruiting
- Advanced Pancreatic Cancer
- JS107
- JS107 combination with Toripalimab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Dec 19, 2022
Pancreatic Tumors Trial in Shanghai (Utidelone injection in combination with gemcitabine)
Recruiting
- Pancreatic Neoplasms
- Utidelone injection in combination with gemcitabine
-
Shanghai, Shanghai, ChinaShanghai First People's Hospital
Mar 21, 2023
Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Homologous Recombination Deficiency
- (no location specified)
Oct 18, 2023
Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Radiation: Diffusing Alpha Radiation
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- (no location specified)
Dec 11, 2022
First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,
Not yet recruiting
- First-line Treatment of Advanced Pancreatic Cancer
- HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
- nab-paclitaxel; gemcitabine
- (no location specified)
Feb 28, 2023
Radiotherapy - Comprehensive Radiobiology Assessment TRial
Not yet recruiting
- Locally Advanced Cervical Carcinoma
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 1, 2023
Pancreatic Cancer Trial in Shanghai (IN10018, Albumin-Bound Paclitaxel, Gemcitabine)
Recruiting
- Pancreatic Cancer
- IN10018
- +3 more
-
Shanghai, Shanghai, ChinaRenji Hospital of Shanghai Jiaotong University School of Medicin
Apr 23, 2023
Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- Locally Advanced
- Later-line therapy
-
Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023
Pancreatic Cancer Trial (MRIdian)
Not yet recruiting
- Pancreatic Cancer
- MRIdian
- (no location specified)
Oct 14, 2022
Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)
Not yet recruiting
- Unresectable Locally Advanced or Metastatic Pancreatic Cancer
- surufatinib
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Apr 16, 2023
Pancreatic Cancer Trial in Bronx (carbon ion RT, Chemotherapy drug)
Suspended
- Pancreatic Cancer
- carbon ion RT
- Chemotherapy drug
-
Bronx, New YorkAlbert Einstein College of Medicine
Jan 24, 2023
Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
- Gemcitabine hydrochloride and albumin binding paclitaxel
-
Shanghai, Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Dec 8, 2022
Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)
Recruiting
- Advanced Pancreatic Cancer
- Solid Tumor Malignancies
-
Bethesda, MarylandNational Cancer Institute
Sep 26, 2022